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ABSTRACT
Dysmenorrhea is defined as symptoms associated with 
menstruation, such as abdominal pain, cramping and 
lumbago, that interfere with daily activity. Primary dys-
menorrhea refers to menstrual pain without underlying 
pathology, whereas secondary dysmenorrhea is menstru-
al pain associated with underlying pathology. Endome-
triosis, one of the main causes of secondary dysmenor-
rhea, induces dysmenorrhea, pelvic pain and infertility, 
resulting in marked reduction of quality of life during 
reproductive age. This review article is a comprehensive 
overview of dysmenorrhea and endometriosis in young 
women. 
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Dysmenorrhea is defined as pathological symptoms asso-
ciated with menstruation, marked by abdominal cramp-
ing and pain during the menstrual period that interfere 
with daily activity. Associated general symptoms, such 
as nausea, vomiting, lumbago, diarrhea, and headache, 
are also common. Dysmennorhea is categorized into two 
types, primary and secondary. Primary dysmenorrhea 
refers to menstrual pain without underlying pathology, 
whereas secondary dysmenorrhea refers to painful men-
struation associated with underlying pathology (Table 1). 
 One study, conducted with the support of the Japan 
Ministry of Health and Welfare, revealed that menstrual 
pain requiring pain medication occurs in 33% of men-
struating Japanese women. In 6% of women, pain medi-
cations were ineffective and bedrest was needed. The 
study results suggest that 1/3 of women who menstruate 
may require medical intervention.1 Ikeda et al., reporting 
the results of a questionnaire survey of menstrual pain 
among high school students, revealed that 90.8% of stu-
dents experienced menstrual pain and that pain affected 
the daily activities of 51.8%. The incidence of menstrual 
pain increased in 3rd grade students (17–18 years old) 
compared with 1st and 2nd grade.2
 The most common cause of secondary dysmenorrhea 
is endometriosis. Endometriosis is an estrogen-dependent 
inflammatory disease characterized by ectopic growth of 
endometrial stroma and glands affecting 5% to 15% of 
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women of reproductive age.3 The main clinical features 
are dysmennorhea, chronic pelvic pain and infertility. 
Endometriosis is a chronic and recurrent disease that ad-
versely affects quality of life in reproductive age women. 
 Sampson’s implantation theory, which describes 
intraperitoneal menstrual reflux leading to spillage of 
endometrial cells into the peritoneal cavity and the result-
ing development of endometrial lesions, is currently the 
prevailing explanation of the pathophysiology of endo-
metriosis. Increased exposure to menstruation in terms of 
short menstrual cycles, prolonged flow and low parity are 
possible risk factors.4 Therefore, retrograde menstruation 
observed in 90% of menstruating women is considered a 
key factor in the pathogenesis of endometriosis.
 Incidence of endometriosis is believed to be increas-
ing because of changes in women’s lifestyle, such as the 
tendency to marry later and have fewer children. This 
life style change increases the number of times a woman 
menstruates and affects the incidence of endometriosis.
 
MECHANISM OF (PRIMARY) DYSMENORRHEA
The etiology of primary dysmenorrhea includes an ex-
cess or imbalance in the amount of prostaglandins (PGs) 
secretion from the endometrium during menstruation. 
Associated general symptoms, such as nausea, vomiting, 
lumbago, diarrhea and headache are the sequel of influx 
of PGs and its derivatives into systemic circulation. Syn-
thesis of arachidonic acids and the pathway of cyclooxy-
genase are activated by a decline of progesterone con-
centrations in the late secretory phase. PG levels in the 
endometrium of the late secretory phase increase 3 times 
higher than those of the proliferative phase. A further 
increase in PG levels is observed during the menstrual 
phase. PGE2 and PGF2 alpha concentrations are higher 
in the menstrual fluid of women with dysmenorrhea than 
in women with painless periods.5 Among PGs, PGF2a is 
considered the most potent causal factor of pain.
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 By preventing ovulation, oral contraceptives (OCs) 
suppress the progesterone-driven proliferation of the 
secretory endometrium, resulting in a decrease in pros-
taglandin synthesis and volume of menstrual fluid.6 
Consistent with Sampson’s theory, reduced menstrual 
flow after taking OCs contributes to reduced retrograde 
menstruation, which then impede the development of 
endometriosis. 
 
MECHANISM OF PAIN DUE TO ENDOMETRIOSIS 
Concentrations of PGs are higher in the menstrual blood 
of women with endometriosis.7 Bulletti et al. found that 
frequency, amplitude and basal pressure tone of uterine 
contractions in women with endometriosis were higher 
than in those without.8 Thus, the severe dysmenorrhea 
of endometriosis patients may be the result of abnormal 
uterine contractions. 
 Endometriotic lesions and adhesions may also cause 
the deep pelvic pain associated with endometriosis. Ac-
tion mechanisms of pain with endometriosis are outlined 
in Table 2. The pain of patients with endometriosis is 
thus due to both uterine contraction and endometriotic le-
sions. 
 
ENDOMETRIOSIS IN YOUNG WOMEN
Retrospective studies report a diagnosis of endometriosis 
in 25% to 38% of adolescents with chronic pelvic pain.9 
Nonsteroidal anti-inflammatory drugs (NSAIDs) and oral 
OCs are prescribed for adolescent patients with chronic 
pelvic pain. If these agents are refractory, endometriosis 
has been diagnosed in 50% to 70% of these patients.10 
These results suggest that endometriosis should be part 
of the differential diagnosis of chronic pelvic or lower ab-
dominal pain in premenarcheal and perimenarcheal girls. 
 While endometriosis usually occurs in women after 
menarche, a series of 5 premenarcheal girls (ages 8.5 
to 13 years) were reported to have endometriosis.11 The 
girls, who all had chronic pelvic pain and a negative 
gastrointestinal workup, were found to have peritoneal 
endometriotic lesions as classified by American Society 
of Reproductive Medicine. Laparoscopic resection or 
cautery of all visible lesions resulted in marked improve-
ment of their pelvic pain.  
 Although Sampson’s theory of retrograde menstrua-
tion and implantation is believed to explain most cases 
of endometriosis, this theory clearly cannot explain 
the cases of endometriosis in premenacheal girls who 
neither menstruate nor have retrograde reflux. A recent 
review by Brosens et al. suggested that endometriosis 
may develop by mechanisms other than retrograde men-
struation and implantation, such as coelomic metaplasia, 
embryonic mullerian rests, or even the persistence of 
the forms of embryonic endometriosis recently de-
scribed.12, 13 They also proposed that the phenomenon of 
uterine bleeding in neonates and concomitant retrograde 
menstruation in the neonate might be a source of stem 
cells that develop into premenarcheal endometriosis.12 
Therefore, it is suggested that premenarcheal and pos-
sibly adolescent endometriosis develop by activation of 
resting stem cells shed at the time of neonatal retrograde 
uterine bleeding. 
 
SYMPTOMS OF ENDOMETRIOSIS IN YOUNG WOM-
EN
Common symptoms in women with endometriosis in-
clude dysmenorrhea, lower abdominal pain and dyspa-
reunia. Almost half of women with endometriosis also 
report their inability to become pregnant. The pain of 
endometriosis in adults is often cyclic while the present-
ing pelvic pain of adolescents can be either acyclic or 
cyclic. Bowel and bladder symptoms commonly occur in 
adolescents (Table 3). The Endometriosis Association’s 
1998 registry of 4,000 adult women with endometriosis 
reported that 2/3 of those responding to the survey ex-
perienced their first pelvic symptoms before 20 years of 
age, 21% before 15, and 17% between 15 to 19.14 
  
Table 2. Mechanism of pain associated with endome-
triosis
A  Pain due to endometriotic lesions
 1 Peritoneal lesions induce inflammatory reactions and secrete 
prostaglandins, cytokines, histamine and kinin that cause 
pain.
 2 Deep infiltrating endometriosis destroys tissues and nerves.
 3 Ruptured chocolate cysts may irritate peritoneum.
B  Scar and fibrosis, secondary lesions
 1 Scar, fibrosis, traction, and adhesion may reduce mobility of 
organs. Pain may occur during movement or ovulation.
 2 Adhesion of bowel may cause defecation pain or dyschezia.
 3 Retroverted uterus due to adhesion, severe adhesion of ovaries 
to Douglas pouch, and induration of sacral ligament may cause 
dyschezia.
Table 1. Differential diagnosis of primary and second-
ary dysmenorrhea
  Primary  Secondary 
 dysmenorrhea  dysmenorrhea 
  Within 3 yr More than 5 yr Onset
 after menarche after menarche
Age 15–25 yr old Over 30 yr old
Aging Gradually improve Become worse
Marriage Improve No change
Postpartum Improve No change
Findings of internal  Endometriosis, 
   examination Normal fibroma, etc.
Time Menstruation
 Menstruation or  
  other time if worse
Duration 4–48 h 1–5 d
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DIAGNOSIS OF ENDOMETRIOSIS IN YOUNG WOM-
EN
Visual inspection by laparoscopy or laparotomy is the 
gold standard for diagnosing endometriosis. However, 
laparoscopy cannot always be performed in daily practice 
in Japan. Therefore, the term, “clinical endometriosis”, is 
used when only patient history, clinical examination and 
ultrasound are available to support the diagnosis. Board 
certified gynecologists can correctly diagnose endome-
triosis in 80% of the patients without laparoscopy. 
 Differential diagnosis is challenging in adolescents 
because there can be coexisting diseases, including 
those of the gastrointestinal system and urinary tract, 
pelvic inflammatory disease, ovarian cysts, obstructive 
anomalies and pregnancy. The presenting symptoms can 
also vary, ranging from only dysmenorrhea, localized 
abdominal pain, dyspareunia, non-cyclic pain or combi-
nations of these symptoms.   
 On examination, ovarian tumor and anomalies of 
the genital tract must be ruled out. We perform transab-
dominal ultrasound examination while the patient has 
a full bladder and rule out abnormalities in the uterus 
and ovaries. We then inspect the genital area and vagina 
and do a rectal examination if necessary. Magnetic reso-
nance imaging (MRI) may also help to reveal an ovarian 
tumor or anomalies. 
LAPAROSCOPIC FINDINGS IN ENDOMETRIOSIS IN 
YOUNG WOMEN
Endometriotic lesions consist of a variety of types, in-
cluding peritoneal implants, ovarian chocolate cysts, 
adhesions, and deep infiltrated endometriosis. Ovarian 
endometrioma is a common disease lesion occurring in 
17% to 44% of endometriosis patients.15 However, the 
finding is rare among adolescents and young women. 
One review over a 15-year period reported no endome-
triomas among the ovarian masses found in 102 infants, 
children and adolescents.16 Peritoneal endometriotic 
lesions are categorized into 3 subgroups: red, black and 
white. Davis et al. reported that red lesions are the pre-
dominant implant type in adolescent patients.17 They 
examined 36 adolescent patients presenting with severe 
dysmenorrhea who were refractory to prior therapy. 
When compared with 46 women aged 31 to 46 years, 
significantly more red lesions were present in adoles-
cents (Table 4). 
 Demco examined endometriotic lesions using pa-
tient-assisted pelvic laparoscopy to determine color and 
size and mapped these areas for pain.18 Of the lesions 
that provoked a pain response, red, vascular lesions were 
the most painful. This finding suggests that red lesions, 
most frequently observed in young patients with endo-
metriosis, may be the cause of their pain. 
 Although, no correlation has been found between 
severity of pain symptoms and stage of the disease or 
site of the endometriotic lesions, laparoscopic resection 
or cautery of the lesions improve symptoms in over 80% 
of patients.
 Clear lesions are common in adolescent endome-
triosis but are often difficult to visualize and evaluate 
laparoscopically. Peritoneal defects or windows, which 
are also diagnostic of endometriosis, are reportedly very 
common in adolescents. Improved visualization and 
identification can often be obtained by increasing the 
laparoscopic magnification.19 
 
CLINICAL MANAGEMENT OF ENDOMETRIOSIS IN 
YOUNG WOMEN
Treatment of endometriosis may be surgical or medi-
cal. Surgical treatment, especially laparoscopic surgery, 
is the most effective method to control pain. Careful 
history and examination is necessary to rule out pelvic 
tumor or inflammatory disease. Young women with dys-
menorrhea should be treated initially with a combination 
of cyclic OCs and NSAIDs. In Japan, 2 cyclic OCs con-
taining low dose estrogen-progestin (LEP) are covered 
by national insurance.20 Side effects, such as nausea 
and atypical bleeding, usually occur during the first 3 
months of therapy, and patients should be advised about 
this. If cyclic administration is not effective, the physi-
cian can recommend a continuous regimen of 3 to 4 
months in which the patient takes the medication, disre-
garding any breakthrough bleeding. After laparoscopic 
surgery for ovarian cysts, a continuous LEP regimen is 
Table 3. Symptoms of endometriosis in young women
Symptoms Frequency
Combination of cyclic and acyclic pain 62.5%
Acyclic pain 28.1%
Cyclic pain 9.4%
Intestinal pain 34.3%
Urinary symptoms 12.5%
Irregular menstruation 9.4%
Abnormal discharge 6.3% 
  Data source: Laufer et al., 1997.10 
Table 4. Red peritoneal lesions in young patients with 
endometriosis
  Age Patients with 
 Number Mean [SD] red lesions
Young patients 36 16.6 [1.4] 86%
LAVH 8 37.4  [3.4] 20%
LAVH, laparoscopically assisted vaginal hysterectomy. 
Data source: Davis et al., 1993.17 
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more effective for pain and results in fewer recurring le-
sions after surgery for ovarian chocolate cysts.21 
 If pain persists with medical management, imaging, 
including ultrasound and MRI, may be ordered to evalu-
ate endometriosis. Laparoscopy, the gold standard for 
diagnosis, and laparoscopic excision of the lesions are 
usually effective for patients with severe pain symptoms. 
 Gonadotropin-releasing hormone (GnRH) agonist 
therapy is widely used for adult patients, but it is not rec-
ommended as a first choice for young women because 
the drug causes significant reduction in bone mineral 
density. A new progestin, dienogest, has been available 
in Japan since 200822 and can be used for management 
of pain associated with endometriosis in young women. 
Dienogest has fewer side effects due to hypoestrogen 
and can be used for more than 1 year in adult patients. 
Data are not available for GnRH agonist and dienogest 
in an adolescent population. These agents may be intro-
duced after establishing the diagnosis of endometriosis 
by laparoscopy.
In summary, LEP and laparoscopic surgery are treat-
ments of choice for young patients with endometriosis. 
Endometriosis is a difficult disease to manage due to its 
chronic and recurrent nature. Long-term management, 
with special attention to preservation of ovarian function, 
is highly important in treating young women with endo-
metriosis. 
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